Aemetis (NASDAQ:AMTX) Upgraded at StockNews.com

StockNews.com upgraded shares of Aemetis (NASDAQ:AMTX) to a sell rating in a report released on Wednesday.

A number of other research firms have also recently commented on AMTX. Ascendiant Capital Markets dropped their target price on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating for the company in a report on Tuesday, September 3rd. HC Wainwright reiterated a “buy” rating and set a $28.00 price objective on shares of Aemetis in a research report on Monday, December 23rd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $12.95.

Aemetis Price Performance

Shares of NASDAQ:AMTX opened at $2.81 on Wednesday. Aemetis has a 1 year low of $2.10 and a 1 year high of $7.03. The stock has a market capitalization of $139.76 million, a price-to-earnings ratio of -1.24 and a beta of 1.35. The company’s 50 day simple moving average is $3.29 and its 200 day simple moving average is $2.99.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.47) by $0.09. The business had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same quarter in the previous year, the business posted ($0.59) EPS. As a group, analysts anticipate that Aemetis will post -2.02 EPS for the current fiscal year.

Institutional Investors Weigh In On Aemetis

Several hedge funds have recently added to or reduced their stakes in the business. Bank of New York Mellon Corp bought a new position in shares of Aemetis during the second quarter worth about $306,000. Rhumbline Advisers increased its position in shares of Aemetis by 2,837.1% during the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after buying an additional 50,528 shares during the period. Hutchinson Capital Management CA bought a new position in Aemetis during the second quarter worth $70,000. Susquehanna Fundamental Investments LLC lifted its holdings in Aemetis by 287.4% in the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after buying an additional 93,536 shares during the period. Finally, FMR LLC boosted its position in Aemetis by 68.2% during the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after acquiring an additional 9,137 shares during the last quarter. 27.02% of the stock is currently owned by institutional investors and hedge funds.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.